- Home
- U vs PODD Comparison
U vs PODD Comparison
Compare U & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | PODD |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0B | 21.0B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | U | PODD |
|---|---|---|
| Price | $19.57 | $243.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 19 |
| Target Price | $40.12 | ★ $366.26 |
| AVG Volume (30 Days) | ★ 23.2M | 1.1M |
| Earning Date | 02-11-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.45 |
| Revenue | $1,849,648,000.00 | ★ $2,521,800,000.00 |
| Revenue This Year | $15.97 | $32.55 |
| Revenue Next Year | $14.03 | $20.54 |
| P/E Ratio | ★ N/A | $72.69 |
| Revenue Growth | 2.01 | ★ 27.11 |
| 52 Week Low | $15.33 | $230.05 |
| 52 Week High | $52.15 | $354.88 |
Technical Indicators
Market Signals| Indicator | U | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 24.77 | 28.88 |
| Support Level | $18.80 | $240.33 |
| Resistance Level | $29.27 | $255.71 |
| Average True Range (ATR) | 2.98 | 8.37 |
| MACD | -1.18 | -0.38 |
| Stochastic Oscillator | 2.99 | 5.28 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.